Summit Securities Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14K Buy
36
+10
+38% +$4.23K ﹤0.01% 789
2026
Q1
$12.3K Sell
26
-211
-89% -$106K ﹤0.01% 627
2025
Q4
$111K Sell
237
-233
-50% -$108K 0.01% 454
2025
Q3
$200K Buy
470
+353
+302% +$137K 0.04% 269
2025
Q2
$44.8K Buy
+117
New +$42.2K 0.01% 544
2024
Q3
Sell
-810
Closed -$260K 701
2024
Q2
$260K Buy
+810
New +$263K 0.05% 147
2023
Q3
Sell
-270
Closed -$82K 764
2023
Q2
$82K Sell
270
-146
-35% -$40.6K 0.01% 318
2023
Q1
$110K Buy
416
+201
+93% +$51.1K 0.01% 279
2022
Q4
$52K Buy
+215
New +$48.2K ﹤0.01% 708
2022
Q3
Sell
-473
Closed -$79K 1027
2022
Q2
$79K Buy
473
+375
+383% +$80.6K 0.01% 452
2022
Q1
$25K Sell
98
-18,127
-99% -$4.55M ﹤0.01% 689
2021
Q4
$4.68M Buy
+18,225
New +$4.46M 0.22% 82

Other funds holding HCA

Summit Securities Group's HCA Position: Q2 2026 in Review

Summit Securities Group increased its HCA Healthcare (HCA) stake by 38% in Q2 2026, buying an estimated $4.23K and bringing the position to 36 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #789.

Summit Securities Group first reported a position in HCA in Q4 2021 and has held it in 12 quarters since. The position peaked at $4.68M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Summit Securities Group held 36 shares of HCA Healthcare worth $14K as of Q2 2026.
  • Summit Securities Group bought 10 HCA Healthcare shares in Q2 2026, an estimated $4.23K.
  • HCA Healthcare made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #789 holding.
  • Summit Securities Group first reported a position in HCA Healthcare in Q4 2021 and has held it in 12 quarters since.
  • Summit Securities Group's HCA Healthcare position peaked at $4.68M in Q4 2021.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.